Bio-Path Holdings, Inc.

BPTH

Exchange: OTC
Industry: Pharmaceutical Preparations
SEC CIK: 0001133818

SEC filings (opens in a new tab)

No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Bio-Path Holdings, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of BPTH: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Q2 2023	Change
Holders	21	18	−3
Shares	570.5K	456.9K	−113.6K (−19.9%)
Value	$793.1K	$812.0K	+$19.0K (+2.4%)

New holders (1)

Institutions that held Bio-Path Holdings, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to BPTH in Q2 2023
Institution	Shares	Value	% of portfolio
Virtu Financial LLC	11,912	$21.0K	0.00%

Sold out (4)

Institutions that held Bio-Path Holdings, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of BPTH in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Walleye Capital LLC	75,024	$104.3K
Citadel Advisors LLC	35,451	$49.3K
Dimensional Fund Advisors LP	13,665	$19.0K
UBS Group AG	1,887	$2.62K